PanGenex (PGXC) and Incredible Discoveries®
Partner in Nationwide Infomercial Campaign for Calci-CLEAR™
TAMPA, Fla. (Business Wire EON) June 27, 2008 --
PanGenex Corporation (Pink Sheets:PGXC) announces that it has signed an
agreement to partner with Incredible Discoveries®
in the launch of a national marketing campaign for Calci-CLEAR™.
Calci-CLEAR is a nutraceutical supplement designed to address
soft-tissue calcification. Calci-CLEAR was formulated following years of
research across a variety of studies and is on the heel of news
organizations and institutions such as the New England Journal of
Medicine, CNN, BusinessWeek, the American College of Cardiology and
others reporting on the findings from the University of California that
states that ‘measuring calcium deposits in the
arteries of the heart is a good predictor of future heart disease.’
Over 196 million people in the United States are diagnosed with diseases
involving soft-tissue calcification at an overall cost to treat such
diseases of $538 billion.
“We are very excited for the opportunity to be
selected by Incredible Discoveries® to bring
Calci-CLEAR to the national marketplace through the production of a
30-minute infomercial, strategic web advertising and continuity
follow-up,” explains Jeff Roman, President and
CEO of PanGenex Corporation. “Over the next
several weeks as the campaign is developed, we will release additional
information to our shareholders about this tremendous opportunity to
partner with an industry leader such as Incredible Discoveries®.”
About Incredible Discoveries®:
Incredible Discoveries®, a wholly-owned
subsidiary of O2Media Inc., is a fully integrated production, marketing
and investment partnership company that introduces new products to
consumers through infomercial development and multi-channel marketing
opportunities, including international retail distribution, the highest
rated live shopping networks, direct mail catalogs, and insert programs.
In addition, Incredible Discoveries® offers a
funding option for select product manufacturers that is totally unique
to the industry. Incredible Discoveries®
hosts a team of dynamic professionals with years of direct response
ingenuity and expertise. Their fresh innovative approach has led to
successful product launches including the Tornado and the Magic Juice
Filter, as well as the international launch of the Didi Car. The
organization is a valued member of the Electronic Retailing Association
(ERA) and the Direct Response Marketing Alliance (DRMA). For more
information about Incredible Discoveries, please visit their website at www.incrediblediscoveries.com.
About PanGenex Corporation:
PanGenex is a publicly traded corporation (Pink Sheets:PGXC) and
pursues business opportunities in the $70 billion nutraceutical and
dietary supplement industry. With a focus on the cardiovascular health
segment, PanGenex develops and markets sector leading, patented or
patent pending, condition specific nutraceuticals and topical
over-the-counter (OTC) drugs and personal care products. Each product is
scientifically formulated to address specific health conditions. Many of
our products contain the purest grade of nutraceutical components
available anywhere without a prescription. PanGenex markets products
through healthcare practitioners, retail establishments and the internet
on websites such as www.PanGenex.com,
www.Calgenex.com and www.HeartHealthyWorld.com.
Disclaimer:
Cautionary Statement about Forward-Looking Statements
This press release contains "forward-looking statements," which are
statements related to future, not past, events. In this context, the
forward-looking statements often include statements regarding our goals,
plans, projections and guidance regarding our financial position,
results of operations, market position, pending and potential future
acquisitions and business strategy, and often contain words such as
"expects," "anticipates," "intends," "plans," "believes," "seeks" or
"will." Any such forward-looking statements are not assurances of future
performance and involve risks and uncertainties that may cause results
to differ materially from those set forth in the statements. These risks
and uncertainties include, among other things, (a) general economic and
business conditions, (b) the level of strategic partner incentives, (c)
the future regulatory environment, (d) our cost of financing, (e) our
ability to complete acquisitions and dispositions and the risks
associated therewith, and (f) our ability to retain key personnel. These
factors, as well as additional factors, could affect our forward-looking
statements. We urge you to carefully consider this information. We
undertake no duty to update our forward-looking statements, including
our earnings outlook. The statements in this press release have not been
evaluated by the Food and Drug Administration. This product is not
intended to diagnose, treat, cure or prevent any disease.
Post Comment:
Trackback URL: http://eon.businesswire.com/pingpr.php/RW1wdC1UaGlyLUNvdXAtUGlnZy1FbXB0LVNpbmctWmVybw==
Bookmark -
Del.icio.us |
Digg |
Furl It |
Spurl |
RawSugar |
Simpy |
Shadows |
Blink It |
My Web
|
